We are thrilled to announce the expansion of our antimicrobial portfolio of events across the Atlantic with the release of
Superbugs & Superdrugs USA, complementing the Group's sell out
Superbugs & Superdrugs European conference which has been running for the past 18 years.
Registration is now live for you to join our growing community in the fight against the global threat of antimicrobial resistance.
With huge interest from leaders in the field including pending confirmations from PAHO/WHO, Astra Zeneca and other senior industry representatives, we have worked closely with an expert panel of speakers to present an agenda that is shaping up to be the best
Superbugs & Superdrugs event to date.
We will continue to offer an unrivalled knowledge-sharing and business networking platform for professionals and senior scientists involved in antimicrobial resistance and infectious disease.
Reasons to join:
- Network with industry-leading experts on drug and antimicrobial material developments
- Learn new funding opportunities from BARDA and US National plans, to combat antimicrobial resistance
- Strengthen your antibiotic pipeline with new insights on microbiome profiling to fight multi-resistant gram negative infections
- Hear important discussions on tackling major bottlenecks that hinder development of new antimicrobial drugs with our star panel line-up
- Discover novel protein-based biologics for the treatment and prevention of serious bacterial infections from Janssen
Plus Two Interactive Half-Day Post-Conference Workshops | Wednesday 16th November 2016
The Use of Animal Models in Pre-Clinical Drug DevelopmentWorkshop Leaders: William Weiss, Director, Pre-Clinical Services, UNT Health Science Center
Mark Pulse, Associate Director, Pre-Clinical Services, UNT Health Science Center
8.30am - 12.30pm
Opportunities and challenges in development of new antibacterial therapeuticsWorkshop Leaders:Dr Tina Guina, Therapeutics Development Project Officer, The National Institute of Allergy and Infectious Diseases
Dr Francois Franceschi, Therapeutics Development Program Officer, The National Institute of Allergy and Infectious Diseases
1.30pm - 5.30pm
''Great meeting to network and have time to discuss face to face. Key questions and issues. Very collaborative open meeting.''
Roche
''It was one of the most useful scientific conferences that I have attended''
BARDA
''Good mix of problems such as funding and novel opportunities and success stories''
TNO
''I enjoyed attending the meeting this year and wanted to thank you for your efforts in organizing it''
UNT Health Science Centre
''I like the mix of early stage technologies and also later stage products being presented''
Sempra Pharmaceuticals
Featured Speakers
- Alita Miller, Head of Bioscience, Entasis Therapeutics
- Annaliesa Anderson, Vice President and CSO Bacterial Vaccines, Pfizer
- Anthony Simon Lynch, Senior Scientific Director, Janssen Fellow & Incubator Leader, Janssen Research & Development, LLC
- Boris Farber, CEO, Noigel, LLC
- Christopher Houchens, Branch Chief, Antibacterials Program, BARDA
- Daniel Obrecht, Chief Scientific Officer, Polyphor
- David Cook, Chief Scientific Officer , Blueberry Therapeutics Ltd.
- David Pompliano, Co-Founder and CSO, Lodo Therapeutics
- Domingo Gargallo-Viola, Co-Founder and CSO, ABAC Therapeutics
- Ian Hayter, Projects Director, Destiny Pharma Ltd
- John Rex, Senior Vice President and Chief Strategy Officer, Infection Business Unit, AstraZeneca
- Mahesh Kumar, Vice President, Global Biological Research and Development, Zoetis
- Olga Lomovskaya, Vice President, Biology, The Medicines Company
- Pilar Ramon-Pardo, Advisor on Clinical Management of Infectious Diseases and Antimicrobial Resistance, PAHO/WHO
- Rosemarie Aurigemma, Chief, Biodefense Drug Development Section, DMID, NIAID, NIH
- Scott Coleman, Head of Nonclinical Development, Spero Therapeutics
- William Weiss, Director of Pre-Clinical Services, University of North Texas Health Science Center
Please fill in your name and email to receive the conference agenda of this event.
The agenda is available as PDF under downloads at the right side of the page.
Venue
Renaissance Woodbridge Hotel
515 US Highway 1 South, 08830
Iselin, NJ, United States
Venue
Renaissance Woodbridge Hotel515 US Highway 1 South
Iselin, New Jersey, USA
